Xtant Medical Holdings Stock Market Value
| XTNT Stock | USD 0.40 0.01 2.44% |
| Symbol | Xtant |
Xtant Medical Holdings Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 0.855 | Quarterly Revenue Growth 0.48 | Return On Assets (0.11) | Return On Equity (0.09) |
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Xtant Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xtant Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xtant Medical.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in Xtant Medical on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding Xtant Medical Holdings or generate 0.0% return on investment in Xtant Medical over 720 days. Xtant Medical is related to or competes with Neuropace, Electromed, Orthopediatrics Corp, SurModics, Paragon 28, LivaNova PLC, and Anika Therapeutics. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for ... More
Xtant Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xtant Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xtant Medical Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 35.77 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 5.71 |
Xtant Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xtant Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xtant Medical's standard deviation. In reality, there are many statistical measures that can use Xtant Medical historical prices to predict the future Xtant Medical's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (1.60) |
Xtant Medical Holdings Backtested Returns
Xtant Medical Holdings shows Sharpe Ratio of -0.13, which attests that the company had a -0.13% return per unit of risk over the last 3 months. Xtant Medical Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Xtant Medical's Market Risk Adjusted Performance of (1.59), standard deviation of 5.57, and Mean Deviation of 3.34 to validate the risk estimate we provide. The firm maintains a market beta of 0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Xtant Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Xtant Medical is expected to be smaller as well. At this point, Xtant Medical Holdings has a negative expected return of -0.73%. Please make sure to check out Xtant Medical's maximum drawdown, as well as the relationship between the daily balance of power and relative strength index , to decide if Xtant Medical Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.73 |
Almost perfect reverse predictability
Xtant Medical Holdings has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Xtant Medical time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xtant Medical Holdings price movement. The serial correlation of -0.73 indicates that around 73.0% of current Xtant Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.73 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Xtant Medical Holdings lagged returns against current returns
Autocorrelation, which is Xtant Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Xtant Medical's stock expected returns. We can calculate the autocorrelation of Xtant Medical returns to help us make a trade decision. For example, suppose you find that Xtant Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Xtant Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Xtant Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Xtant Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Xtant Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Xtant Medical Lagged Returns
When evaluating Xtant Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Xtant Medical stock have on its future price. Xtant Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Xtant Medical autocorrelation shows the relationship between Xtant Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Xtant Medical Holdings.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.